[
  {
    "ts": "2025-12-04T12:00:00+00:00",
    "headline": "Insulet Announces FDA 510(k) Clearance of Omnipod速 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience",
    "summary": "ACTON, Mass., December 04, 2025--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod速 brand of products, today announced it has received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. These updates to the Omnipod 5 algorithm set a new benchmark in tubeless diabetes technology by offering a lower 100 mg/dL Target Glucose option and a more seamless automated experi",
    "url": "https://finance.yahoo.com/news/insulet-announces-fda-510-k-120000989.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "4112f523-34b2-3145-82fb-553f7263b187",
      "content": {
        "id": "4112f523-34b2-3145-82fb-553f7263b187",
        "contentType": "STORY",
        "title": "Insulet Announces FDA 510(k) Clearance of Omnipod速 5 Algorithm Enhancements that Redefine Insulin Delivery and Simplify the Pod Experience",
        "description": "",
        "summary": "ACTON, Mass., December 04, 2025--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod速 brand of products, today announced it has received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. These updates to the Omnipod 5 algorithm set a new benchmark in tubeless diabetes technology by offering a lower 100 mg/dL Target Glucose option and a more seamless automated experi",
        "pubDate": "2025-12-04T12:00:00Z",
        "displayTime": "2025-12-04T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/8aafde81f2e626162efd4c9a63666fea",
          "originalWidth": 480,
          "originalHeight": 236,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ti04Babnrrqhoicdsad0Tw--~B/aD0yMzY7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8aafde81f2e626162efd4c9a63666fea.cf.webp",
              "width": 480,
              "height": 236,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/R7D8O6EAHkxiBk6lgt0qwg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8aafde81f2e626162efd4c9a63666fea.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/insulet-announces-fda-510-k-120000989.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/insulet-announces-fda-510-k-120000989.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PODD"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]